Avanir Encouraged Nuedexta Use for Off-Label Purposes Complaint

May 20, 2022

When drugs are approved by the Food and Drug Administration (FDA), they are approved for specific uses, to treat specific diseases or problems. The complaint for this class action brings suit against Avanir Pharmaceuticals, Inc., which it claims attempted to market a drug called Nuedexta for other than its original uses, including, it claims, by offering kickbacks to doctors to prescribe it for other conditions.